These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37784143)

  • 1. An alpha-helix variant p.Arg156Pro in LMNA as a cause of hereditary dilated cardiomyopathy: genetics and bioinfomatics exploration.
    Chang L; Huang R; Chen J; Li G; Shi G; Xu B; Wang L
    BMC Med Genomics; 2023 Oct; 16(1):229. PubMed ID: 37784143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
    Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
    J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
    Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
    Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated Cardiomyopathy.
    Kawakami H; Ogimoto A; Tokunaga N; Nishimura K; Kawakami H; Higashi H; Iio C; Kono T; Aono J; Uetani T; Nagai T; Inoue K; Suzuki J; Ikeda S; Okura T; Ohyagi Y; Tabara Y; Higaki J
    Int Heart J; 2018 May; 59(3):531-541. PubMed ID: 29628476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutations in LMNA associated with familial forms of dilated cardiomyopathy.
    Stallmeyer B; Koopmann M; Schulze-Bahr E
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):543-9. PubMed ID: 22224630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lamin A/C mutations in dilated cardiomyopathy.
    Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
    Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
    Zhang X; Shao X; Zhang R; Zhu R; Feng R
    Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.
    Morival JLP; Widyastuti HP; Nguyen CHH; Zaragoza MV; Downing TL
    Clin Epigenetics; 2021 Jul; 13(1):139. PubMed ID: 34246298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of late sodium current attenuates ionic arrhythmia mechanism in ventricular myocytes expressing LaminA-N195K mutation.
    Markandeya YS; Tsubouchi T; Hacker TA; Wolff MR; Belardinelli L; Balijepalli RC
    Heart Rhythm; 2016 Nov; 13(11):2228-2236. PubMed ID: 27498076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamin A/C deficiency-mediated ROS elevation contributes to pathogenic phenotypes of dilated cardiomyopathy in iPSC model.
    Qiu H; Sun Y; Wang X; Gong T; Su J; Shen J; Zhou J; Xia J; Wang H; Meng X; Fu G; Zhang D; Jiang C; Liang P
    Nat Commun; 2024 Aug; 15(1):7000. PubMed ID: 39143095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The LMNA p.R541C mutation causes dilated cardiomyopathy in human and mice.
    Yang L; Sun J; Chen Z; Liu L; Sun Y; Lin J; Hu X; Zhao M; Ma Y; Lu D; Li Y; Guo Y; Dong E
    Int J Cardiol; 2022 Sep; 363():149-158. PubMed ID: 35714719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice.
    Mounkes LC; Kozlov SV; Rottman JN; Stewart CL
    Hum Mol Genet; 2005 Aug; 14(15):2167-80. PubMed ID: 15972724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations.
    Sébillon P; Bouchier C; Bidot LD; Bonne G; Ahamed K; Charron P; Drouin-Garraud V; Millaire A; Desrumeaux G; Benaïche A; Charniot JC; Schwartz K; Villard E; Komajda M
    J Med Genet; 2003 Aug; 40(8):560-7. PubMed ID: 12920062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.